Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$433M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$419M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$332M |
| 5 |
RTX Corp
RTX
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$267M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.07% |
| 2 | Financials | 5.97% |
| 3 | Healthcare | 5.8% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MXWL
4426
PUT
DELISTED
Maxwell Technologies Inc
MXWL
| $250K | ﹤0.01% |
43,400
+1,800
| +4% | +$9.37K |
|
|
NEE.PRQ
4427
DELISTED
NextEra Energy, Inc.
NEE.PRQ
| $250K | ﹤0.01% |
3,600
-21,400
| -86% | -$1.48M |
|
4428
Canadian Natural Resources
CNQ
$95.1B
| $249K | ﹤0.01% |
14,198
+2,032
| +17% | +$34.1K |
|
4429
PUT
F5
FFIV
$22.9B
| $249K | ﹤0.01% |
1,900
-5,200
| -73% | -$646K |
|
4430
Morningstar
MORN
$7.48B
| $249K | ﹤0.01% |
2,571
-1,834
| -42% | -$165K |
|
4431
PUT
Bank of Montreal
BMO
$127B
| $248K | ﹤0.01% |
3,100
-3,500
| -53% | -$273K |
|
4432
Camping World
CWH
$659M
| $248K | ﹤0.01% |
5,560
-1,172
| -17% | -$51K |
|
4433
SK Telecom
SKM
$13.3B
| $248K | ﹤0.01% |
5,400
-1,043
| -16% | -$45.5K |
|
4434
Theravance Biopharma
TBPH
$877M
| $248K | ﹤0.01% |
8,892
+6,562
| +282% | +$194K |
|
4435
PUT
Rockwell Medical
RMTI
$28.4M
| $247K | ﹤0.01% |
385
+173
| +82% | +$122K |
|
4436
CALL
Webster Financial
WBS
$12.8B
| $247K | ﹤0.01% |
4,400
+1,800
| +69% | +$98.5K |
|
4437
Agree Realty
ADC
$9.4B
| $246K | ﹤0.01% |
4,790
-5,092
| -52% | -$252K |
|
4438
FB Financial Corp
FBK
$3.05B
| $246K | ﹤0.01% |
5,853
+1,850
| +46% | +$75.1K |
|
4439
Innoviva
INVA
$1.49B
| $246K | ﹤0.01% |
17,354
-16,541
| -49% | -$221K |
|
4440
PUT
ResMed
RMD
$30.3B
| $246K | ﹤0.01% |
2,900
+600
| +26% | +$49.6K |
|
|
FLG
4441
PUT
Flagstar Bank National Association
FLG
$5.88B
| $246K | ﹤0.01% |
6,300
+2,367
| +60% | +$91.6K |
|
4442
PUT
Cameco
CCJ
$42.5B
| $245K | ﹤0.01% |
26,500
+22,600
| +579% | +$212K |
|
4443
MYR Group
MYRG
$5.27B
| $245K | ﹤0.01% |
6,834
+781
| +13% | +$25.9K |
|
|
IPHS
4444
DELISTED
Innophos Holdings, Inc.
IPHS
| $245K | ﹤0.01% |
5,263
+2,502
| +91% | +$117K |
|
|
FTD
4445
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $245K | ﹤0.01% |
34,072
+32,743
| +2,464% | +$304K |
|
4446
Santander
BSBR
$43.6B
| $244K | ﹤0.01% |
26,384
| – | – |
|
4447
PUT
Groupon
GRPN
$945M
| $244K | ﹤0.01% |
2,390
+500
| +26% | +$52.6K |
|
4448
Helios Technologies
HLIO
$2.74B
| $244K | ﹤0.01% |
3,759
-3,630
| -49% | -$212K |
|
4449
WSFS Financial
WSFS
$4.15B
| $244K | ﹤0.01% |
5,117
+4,415
| +629% | +$218K |
|
|
TVRD
4450
Tvardi Therapeutics
TVRD
$23.4M
| $244K | ﹤0.01% |
554
-1,827
| -77% | -$833K |
|
Similar funds
Barclays's Q4 2017 Portfolio in Review
As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.
- Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
- Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
- Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
- Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
- Barclays opened 435 new positions and closed 356 in Q4 2017.
- Barclays's portfolio value rose 26% quarter-over-quarter to $122B.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.